Onsdag 22 April | 12:52:16 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-11-05 18:30 Kvartalsrapport 2026-Q3
2026-08-20 18:30 Kvartalsrapport 2026-Q2
2026-05-08 N/A X-dag ordinarie utdelning MCLR 0.00 SEK
2026-05-07 18:30 Kvartalsrapport 2026-Q1
2026-02-19 - Bokslutskommuniké 2025
2025-11-06 - Kvartalsrapport 2025-Q3
2025-08-21 - Kvartalsrapport 2025-Q2
2025-05-09 - X-dag ordinarie utdelning MCLR 0.00 SEK
2025-05-08 - Kvartalsrapport 2025-Q1
2025-04-16 - Årsstämma
2025-02-28 - Bokslutskommuniké 2024
2024-11-07 - Kvartalsrapport 2024-Q3
2024-08-09 - Kvartalsrapport 2024-Q2
2024-05-14 - Kvartalsrapport 2024-Q1
2024-04-19 - X-dag ordinarie utdelning MCLR 0.00 SEK
2024-04-18 - Årsstämma
2024-02-28 - Bokslutskommuniké 2023
2023-11-02 - Kvartalsrapport 2023-Q3
2023-08-23 - Kvartalsrapport 2023-Q2
2023-05-11 - X-dag ordinarie utdelning MCLR 0.00 SEK
2023-05-11 - Årsstämma
2023-05-10 - Kvartalsrapport 2023-Q1
2023-02-23 - Bokslutskommuniké 2022
2022-11-03 - Kvartalsrapport 2022-Q3
2022-08-11 - Kvartalsrapport 2022-Q2
2022-05-05 - Kvartalsrapport 2022-Q1
2022-04-07 - X-dag ordinarie utdelning MCLR 0.00 SEK
2022-04-06 - Årsstämma
2022-02-23 - Bokslutskommuniké 2021
2021-08-19 - Kvartalsrapport 2021-Q2
2021-06-02 - X-dag ordinarie utdelning MCLR 0.00 SEK
2021-03-03 - Extra Bolagsstämma 2021
2021-02-23 - Bokslutskommuniké 2020
2020-08-19 - Kvartalsrapport 2020-Q2
2020-06-11 - X-dag ordinarie utdelning MCLR 0.00 SEK
2020-06-10 - Årsstämma
2020-02-21 - Bokslutskommuniké 2019
2019-08-22 - Kvartalsrapport 2019-Q2
2019-05-22 - X-dag ordinarie utdelning MCLR 0.00 SEK
2019-05-21 - Årsstämma
2018-08-23 - Kvartalsrapport 2018-Q2
2018-05-17 - X-dag ordinarie utdelning MCLR 0.00 SEK
2018-05-16 - Årsstämma
2018-02-16 - Bokslutskommuniké 2017
2017-08-25 - Kvartalsrapport 2017-Q2
2017-05-19 - X-dag ordinarie utdelning MCLR 0.00 SEK
2017-05-18 - Årsstämma

Beskrivning

LandSverige
ListaNordic SME Sweden
SektorHandel & varor
IndustriSällanköpsvaror
Medclair är ett svenskt cleantech-bolag som utvecklar teknik för hållbar hantering av lustgas inom sjukvård, återvinningsindustri och andra branscher med lustgasanvändning. Bolaget har en etablerad internationell närvaro och erbjuder lösningar som ämnar till att både minska klimatpåverkan och förbättra arbetsmiljön. Huvudkontoret ligger i Stockholm.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-04-22 09:30:00

Medclair AB has received a conditional order regarding a system solution for the destruction of nitrous oxide emissions from a company within the global environmental group Veolia. The deal, valued at approximately SEK 3.65 million, includes an installation for the destruction of nitrous oxide (N2O) from gas cylinders within the recycling industry.

Through this order, Medclair establishes a new significant customer relationship in a new geographical market in Europe for the company. Experience from previous collaborations with other units within the Veolia Group shows that solutions in this segment often lead to a long-term and recurring need among customers, which opens the door for further growth.

The installation is estimated to reduce the customer's carbon footprint by over 1.6 million kg N2O. The system is a proven solution for safely emptying and destroying nitrous oxide in gas cylinders, ensuring that the gas does not reach the atmosphere while simultaneously providing a safe working environment.

The investment is approved and budgeted by the customer. Delivery and the formal purchase order are conditional upon local authority permits, which are expected to be in place during the second half of 2026.

"We are very proud to welcome a new customer within the Veolia Group and at the same time take the step into a completely new geographical market for us. Within the recycling segment, we see a clear pattern where the first deal often serves as the starting point for a long-term collaboration with recurring orders. The fact that we are now establishing our technology for the destruction of gas cylinders in a new region is a testament to our strength, confirming the scalability and international potential of our solutions," says Jonas Lundh, CEO of Medclair.